Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
Rangering i aksjer #14725
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
Aksjekurs
$34.40
Sist synkronisert: 2025-08-11
Markedsverdi
$396.01M
Endring (1 dag)
1.83%
Endring (1 år)
0.00%
Land
DE
Handel PharmaSGP Holding SE (PSG)

Kategori

Pris PSG pris med markedsverdi på B
PharmaSGP Holding SE PharmaSGP Holding SE
PSG
$34.40
Markedsverdi av PharmaSGP Holding SE(PSG)
Markedsverdi: $396.01M
Per September 2026 har PharmaSGP Holding SE en markedsverdi på $396.01M. Dette gjør PharmaSGP Holding SE til det 14725th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PharmaSGP Holding SE fra 2011 til 2026
PSG sammenlignet med topp 5 mest populære stocks
Pris på PSG Eiendel B Markedsverdi for B Resultater
PharmaSGP Holding SE PharmaSGP Holding SE
$462,697 $396.01M
$5.327T +1,345,009.15%
PharmaSGP Holding SE PharmaSGP Holding SE
$403,464 $396.01M
$4.645T +1,172,810.86%
PharmaSGP Holding SE PharmaSGP Holding SE
$353,551 $396.01M
$4.070T +1,027,710.47%
PharmaSGP Holding SE PharmaSGP Holding SE
$328,737 $396.01M
$3.785T +955,571.34%
PharmaSGP Holding SE PharmaSGP Holding SE
$242,356 $396.01M
$2.790T +704,453.82%